Literature DB >> 27632788

Real-Time H2 O2 Measurements in Bone Marrow Mesenchymal Stem Cells (MSCs) Show Increased Antioxidant Capacity in Cells From Osteoporotic Women.

Flavia Román1, Carla Urra1, Omar Porras1, Ana María Pino1, Clifford J Rosen2, Juan Pablo Rodríguez1.   

Abstract

Oxidative stress (OS) derived from an increase in intracellular reactive oxygen species (ROS) is a major determinant of aging and lifespan. It has also been associated with several age-related disorders, like postmenopausal osteoporosis of Mesenchymal stem cells (MSCs). MSCs are the common precursors for osteoblasts and adipocytes; appropriate commitment and differentiation of MSCs into a specific phenotype is modulated, among other factors, by ROS balance. MSCs have shown more resistance to ROS than differentiated cells, and their redox status depends on complex and abundant anti-oxidant mechanisms. The purpose of this work was to analyze in real time, H2 O2 signaling in individual h-MSCs, and to compare the kinetic parameters of H2 O2 management by cells derived from both control (c-) and osteoporotic (o-) women. For these purposes, cells were infected with a genetically encoded fluorescent biosensor named HyPer, which is specific for detecting H2 O2 inside living cells. Subsequently, cells were sequentially challenged with 50 and 500 μM H2 O2 pulses, and the cellular response was recorded in real time. The results demonstrated adequate expression of the biosensor allowing registering fluorescence from HyPer at a single cell level. Comparison of the response of c- and o-MSCs to the oxidant challenges demonstrated improved antioxidant activity in o-MSCs. This was further corroborated by measuring the relative expression of mRNAs for catalase, superoxide dismutase-1, thioredoxine, and peroxiredoxine, as well as by cell-surviving capacity under short-term H2 O2 treatment. We conclude that functional differences exist between healthy and osteoporotic human MSCs. The mechanism for these differences requires further study. J. Cell. Biochem. 118: 585-593, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ANTIOXIDANT CAPACITY; MESENCHYMAL STEM CELLS; OSTEOPOROSIS

Mesh:

Substances:

Year:  2016        PMID: 27632788     DOI: 10.1002/jcb.25739

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Microvesicles as Potential Biomarkers for the Identification of Senescence in Human Mesenchymal Stem Cells.

Authors:  Qian Lei; Teng Liu; Fei Gao; Hui Xie; Li Sun; Aiqi Zhao; Wenxiang Ren; Hao Guo; Liming Zhang; Hongxiang Wang; Zhichao Chen; An-Yuan Guo; Qiubai Li
Journal:  Theranostics       Date:  2017-07-06       Impact factor: 11.556

2.  Insights into the HyPer biosensor as molecular tool for monitoring cellular antioxidant capacity.

Authors:  Helen Hernández; Alejandra Parra; Nicolas Tobar; Jessica Molina; Violeta Kallens; Miltha Hidalgo; Diego Varela; Jorge Martínez; Omar Porras
Journal:  Redox Biol       Date:  2018-03-02       Impact factor: 11.799

3.  MiR-128 inhibits the osteogenic differentiation in osteoporosis by down-regulating SIRT6 expression.

Authors:  Jindong Zhao; Shaohui Liu; Wenhui Zhang; Linying Ni; Zhenming Hu; Zhigang Sheng; Bo Yin
Journal:  Biosci Rep       Date:  2019-09-24       Impact factor: 3.840

4.  New strategy of bone marrow mesenchymal stem cells against oxidative stress injury via Nrf2 pathway: oxidative stress preconditioning.

Authors:  Fei Zhang; Wuxun Peng; Jian Zhang; Wentao Dong; Dajiang Yuan; Yinggang Zheng; Zhenwen Wang
Journal:  J Cell Biochem       Date:  2019-07-26       Impact factor: 4.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.